東方雨虹(002271.SZ):擬斥7億元在邵陽經開區投建新材料生產項目
格隆匯12月25日丨東方雨虹(002271.SZ)宣佈,2020年12月25日,公司與邵陽經濟開發區管理委員會簽訂《東方雨虹新材料生產項目引進合同》,合同約定公司擬投資7億元在湖南省邵陽市經濟開發區投資建設東方雨虹新材料生產項目,建設內容為新材料生產及配套項目生產。
該項目分兩期開發建設,其中一期項目擬投資2億元,建設週期為在交地後自辦妥《不動產登記證書(純土地)》、《建設規劃許可證》、《建築工程施工許可證》三證之日起30日內開工建設,一年半內完成項目施工建設並投產;二期項目於一期建成後啟動,擬投資金額5億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.